Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202813012 | Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1475927017 | Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5mg/1.6mg suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1476888019 | Hydrocortisone+neomycin sulfate+polymyxin b sulfate 10mg/5mg/1.6mg suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3110291000052117 | hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Is a | Product containing hydrocortisone (medicinal product) | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Is a | Product containing neomycin (medicinal product) | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Is a | Compound neomycin preparations | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Is a | Hydrocortisone-containing product in otic dose form | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Is a | Product containing polymyxin B (medicinal product) | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | Polymyxin B (substance) | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | Neomycin (substance) | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Is a | hydrokortison + neomycinsulfat + polymyxin B-sulfat | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | Polymyxin B sulfate (substance) | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | Hydrocortisone (substance) | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | antiinfektivt medel för huden | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | Neomycin sulfate | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | binjurehormonmedel | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Has manufactured dose form | Otic dose form (dose form) | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Is a | Polymyxin B-containing product in otic dose form | false | Inferred relationship | Some | ||
| hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension | Is a | Product containing neomycin in otic dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR